_id

690da941ccc777a4e85d083a

Ticker

ACRV

Name

Acrivon Therapeutics, Inc. Common Stock

Exchange

NASDAQ

Address

480 Arsenal Way, Watertown, MA, United States, 02472

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://acrivon.com

Description

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. Acrivon Therapeutics, Inc. was incorporated in 2018 and is based in Watertown, Massachusetts.

Last Close

2.61

Volume

286911

Current Price

2.53

Change

-3.065134099616861

Last Updated

2025-11-28T11:49:40.470Z

Image

data:image/webp;base64,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

Ipo Date

2022-11-15T00:00:00.000Z

Market Cap

74470096

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.018500000000000016

Sentiment Sources

2

Rating

4.3333

Target Price

11.1667

Strong Buy

4

Buy

4

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

300000

Gross Profit

-300000

Operating Expenses

19387000

Operating Income

-19687000

Interest Expense

-

Pretax Income

-18234000

Net Income

-18234000

Eps

-0.4728677538735011

Dividends Per Share

-

Shares Outstanding

31555126

Income Tax Expense

-

EBITDA

-17934000

Operating Margin

-

Total Other Income Expense Net

1453000

Cash

35405000

Short Term Investments

93849000

Receivables

-

Inventories

-

Total Current Assets

130361000

Property Plant Equipment

7981000

Total Assets

145299000

Payables

996000

Short Term Debt

1184000

Long Term Debt

-

Total Liabilities

16696000

Equity

128603000

Depreciation

300000

Change In Working Capital

1466000

Cash From Operations

-12283000

Capital Expenditures

899000

Cash From Investing

5911000

Cash From Financing

-117000

Net Change In Cash

-6490000

PE

-

PB

0.7585979636555912

ROE

-14.17851838604076

ROA

-12.54929490223608

FCF

-13182000

Fcf Percent

-

Piotroski FScore

1

Health Score

42

Deep Value Investing Score

5.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

6

Quality Investing Score

2.5

Value Investing Score

5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

300000

Quarters > 0 > income Statement > gross Profit

-300000

Quarters > 0 > income Statement > operating Expenses

19387000

Quarters > 0 > income Statement > operating Income

-19687000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-18234000

Quarters > 0 > income Statement > net Income

-18234000

Quarters > 0 > income Statement > eps

-0.4728677538735011

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

38560464

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-17934000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1453000

Quarters > 0 > balance Sheet > cash

35405000

Quarters > 0 > balance Sheet > short Term Investments

93849000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

130361000

Quarters > 0 > balance Sheet > property Plant Equipment

7981000

Quarters > 0 > balance Sheet > total Assets

145299000

Quarters > 0 > balance Sheet > payables

996000

Quarters > 0 > balance Sheet > short Term Debt

1184000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

16696000

Quarters > 0 > balance Sheet > equity

128603000

Quarters > 0 > cash Flow > net Income

-18234000

Quarters > 0 > cash Flow > depreciation

300000

Quarters > 0 > cash Flow > change In Working Capital

1466000

Quarters > 0 > cash Flow > cash From Operations

-12283000

Quarters > 0 > cash Flow > capital Expenditures

899000

Quarters > 0 > cash Flow > cash From Investing

5911000

Quarters > 0 > cash Flow > cash From Financing

-117000

Quarters > 0 > cash Flow > net Change In Cash

-6490000

Quarters > 0 > ratios > PE

-0.4728677538735011

Quarters > 0 > ratios > PB

0.7585979636555912

Quarters > 0 > ratios > ROE

-14.17851838604076

Quarters > 0 > ratios > ROA

-12.54929490223608

Quarters > 0 > ratios > FCF

-13182000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

42

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

300000

Quarters > 1 > income Statement > gross Profit

-300000

Quarters > 1 > income Statement > operating Expenses

22349000

Quarters > 1 > income Statement > operating Income

-22649000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-21006000

Quarters > 1 > income Statement > net Income

-21006000

Quarters > 1 > income Statement > eps

-0.5461548563517308

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

38461619

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-20706000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1643000

Quarters > 1 > balance Sheet > cash

41895000

Quarters > 1 > balance Sheet > short Term Investments

95528000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

138412000

Quarters > 1 > balance Sheet > property Plant Equipment

8124000

Quarters > 1 > balance Sheet > total Assets

158583000

Quarters > 1 > balance Sheet > payables

1163000

Quarters > 1 > balance Sheet > short Term Debt

1148000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

15546000

Quarters > 1 > balance Sheet > equity

143037000

Quarters > 1 > cash Flow > net Income

-21006000

Quarters > 1 > cash Flow > depreciation

162000

Quarters > 1 > cash Flow > change In Working Capital

52000

Quarters > 1 > cash Flow > cash From Operations

-16610000

Quarters > 1 > cash Flow > capital Expenditures

493000

Quarters > 1 > cash Flow > cash From Investing

19451000

Quarters > 1 > cash Flow > cash From Financing

-97000

Quarters > 1 > cash Flow > net Change In Cash

2744000

Quarters > 1 > ratios > PE

-0.5461548563517308

Quarters > 1 > ratios > PB

0.6802987763305997

Quarters > 1 > ratios > ROE

-14.685710690240986

Quarters > 1 > ratios > ROA

-13.24606042261781

Quarters > 1 > ratios > FCF

-17103000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

311000

Quarters > 2 > income Statement > gross Profit

-311000

Quarters > 2 > income Statement > operating Expenses

21351000

Quarters > 2 > income Statement > operating Income

-21662000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-19680000

Quarters > 2 > income Statement > net Income

-19680000

Quarters > 2 > income Statement > eps

-0.5131622465700788

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

38350444

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-19369000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1982000

Quarters > 2 > balance Sheet > cash

39154000

Quarters > 2 > balance Sheet > short Term Investments

110481000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

151327000

Quarters > 2 > balance Sheet > property Plant Equipment

7982000

Quarters > 2 > balance Sheet > total Assets

176349000

Quarters > 2 > balance Sheet > payables

3691000

Quarters > 2 > balance Sheet > short Term Debt

1105000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

15959000

Quarters > 2 > balance Sheet > equity

160390000

Quarters > 2 > cash Flow > net Income

-19680000

Quarters > 2 > cash Flow > depreciation

311000

Quarters > 2 > cash Flow > change In Working Capital

-3845000

Quarters > 2 > cash Flow > cash From Operations

-19535000

Quarters > 2 > cash Flow > capital Expenditures

58000

Quarters > 2 > cash Flow > cash From Investing

19214000

Quarters > 2 > cash Flow > cash From Financing

-343000

Quarters > 2 > cash Flow > net Change In Cash

-664000

Quarters > 2 > ratios > PE

-0.5131622465700788

Quarters > 2 > ratios > PB

0.6049418499906477

Quarters > 2 > ratios > ROE

-12.270091651599227

Quarters > 2 > ratios > ROA

-11.159689025738734

Quarters > 2 > ratios > FCF

-19593000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

848000

Quarters > 3 > income Statement > cost Of Revenue

303000

Quarters > 3 > income Statement > gross Profit

-303000

Quarters > 3 > income Statement > operating Expenses

24651000

Quarters > 3 > income Statement > operating Income

-24954000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-22831000

Quarters > 3 > income Statement > net Income

-22831000

Quarters > 3 > income Statement > eps

-0.597007322655276

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

38242412

Quarters > 3 > income Statement > income Tax Expense

-180724

Quarters > 3 > income Statement > EBITDA

-22528000

Quarters > 3 > income Statement > operating Margin

-2942.688679245283

Quarters > 3 > income Statement > total Other Income Expense Net

2123000

Quarters > 3 > balance Sheet > cash

39818000

Quarters > 3 > balance Sheet > short Term Investments

139662000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

181629000

Quarters > 3 > balance Sheet > property Plant Equipment

8025000

Quarters > 3 > balance Sheet > total Assets

196588000

Quarters > 3 > balance Sheet > payables

758000

Quarters > 3 > balance Sheet > short Term Debt

1057000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

19802000

Quarters > 3 > balance Sheet > equity

176786000

Quarters > 3 > cash Flow > net Income

-22831000

Quarters > 3 > cash Flow > depreciation

303000

Quarters > 3 > cash Flow > change In Working Capital

2115000

Quarters > 3 > cash Flow > cash From Operations

-17360000

Quarters > 3 > cash Flow > capital Expenditures

827000

Quarters > 3 > cash Flow > cash From Investing

14412000

Quarters > 3 > cash Flow > cash From Financing

-647000

Quarters > 3 > cash Flow > net Change In Cash

-3595000

Quarters > 3 > ratios > PE

-0.597007322655276

Quarters > 3 > ratios > PB

0.5472905227789531

Quarters > 3 > ratios > ROE

-12.91448417861143

Quarters > 3 > ratios > ROA

-11.613628502248357

Quarters > 3 > ratios > FCF

-18187000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-21.44693396226415

Quarters > 3 > health Score

34

Valuation > metrics > PE

-0.4728677538735011

Valuation > metrics > PB

0.7585979636555912

Valuation > final Score

70

Valuation > verdict

24.1% Undervalued

Profitability > metrics > ROE

-14.17851838604076

Profitability > metrics > ROA

-13.987312156243048

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.12982589830719346

Risk > metrics > Interest Coverage

-65.62333333333333

Risk > final Score

-202

Risk > verdict

High

Liquidity > metrics > Current Ratio

59.79862385321101

Liquidity > metrics > Quick Ratio

59.79862385321101

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-242

Prev Risks > 1

-219

Prev Risks > 2

-269

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:11:44.933Z